SCHEMBL1029918

SCHEMBL1029918

Clc1ccc(Cl)c(-c2ccnc(NC3CCCCC3)n2)c1

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPK8 P45983 4/20 0.60
MAPK9 P45984 4/20 0.60
MAPK10 P53779 4/20 0.60
EIF2AK2 P19525 1/20 0.56
CDK1 P06493 6/20 0.55
CCNB1 P14635 6/20 0.55
CDK4 P11802 4/20 0.55
CDK2 P24941 4/20 0.55
CCNA2 P20248 3/20 0.55
CCND1 P24385 3/20 0.55
CCNA1 P78396 3/20 0.55
CCNB2 O95067 3/20 0.53
CCNB3 Q8WWL7 3/20 0.53
GSK3B P49841 3/20 0.53
CDC7 O00311 1/20 0.53
PLK4 O00444 1/20 0.53
JAK2 O60674 1/20 0.53
MAP4K4 O95819 1/20 0.53
INSR P06213 1/20 0.53
CSF1R P07333 1/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1032136 0.84 SMN1; SMN2 (0.62) MAPK8MAPK9MAPK10EIF2AK2CDK1
SCHEMBL3620677 0.84 SMN1; SMN2 (0.62) MAPK8MAPK9MAPK10EIF2AK2CDK1
SCHEMBL1034516 0.83 SMN1; SMN2 (0.60) MAPK8MAPK9MAPK10EIF2AK2CDK1
SCHEMBL1032138 0.81 IKBKB (0.76) MAPK8MAPK9MAPK10EIF2AK2CDK1
SCHEMBL1033923 0.80 IKBKB (0.59) MAPK8MAPK9MAPK10EIF2AK2CDK1
SCHEMBL3619159 0.80 ADORA1 (0.59) MAPK8MAPK9MAPK10EIF2AK2CDK1
SCHEMBL1030530 0.80 ADORA1 (0.59) MAPK8MAPK9MAPK10EIF2AK2CDK1
SCHEMBL1034791 0.78 MAPK1 (0.54) MAPK8MAPK9MAPK10CDK1CCNB1
SCHEMBL1033580 0.77 CDK1 (0.55) MAPK8MAPK9MAPK10EIF2AK2CDK1
SCHEMBL18941035 0.75 CDK2 (0.64) MAPK8MAPK9MAPK10EIF2AK2CDK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2010151747-A1 PYRIMINE COMPOUNDS AND METHODS OF MAKING AND USING SAME CYSTIC FIBROSIS FOUNDATION THERAPEUTICS, INC. (US) 2010-12-29 WO claimed
WO-2011008931-A2 ARYLPYRIMIDINE COMPOUNDS AND COMBINATION THERAPY COMPRISING SAME FOR TREATING CYSTIC FIBROSIS & RELATED DISORDERS CYSTIC FIBROSIS FOUNDATION THERAPEUTICS, INC. (US) 2011-01-20 WO disclosed
WO-2010151747-A1 PYRIMINE COMPOUNDS AND METHODS OF MAKING AND USING SAME CYSTIC FIBROSIS FOUNDATION THERAPEUTICS, INC. (US) 2010-12-29 WO disclosed